← Back to Search

Behavioral Intervention

Organizational Strategy for Substance Abuse Care Improvement (LOCI-SL Trial)

N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline through study completion, an average of 9 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a strategy to help clinics implement and sustain the use of an AI platform to improve care for substance abuse disorders.

Who is the study for?
This trial is for staff at provider or payer advocacy organizations, executives and managers at substance use disorder/mental health treatment agencies, clinic supervisors, counselors providing such treatments in Oregon and Indiana. It includes stakeholders from relevant state authorities and managed care organizations.
What is being tested?
The trial tests a strategy called LOCI-SL that aligns leadership across systems to implement the Lyssn AI platform for Motivational Interviewing (MI) and evidence-based practices in treating substance use disorders.
What are the potential side effects?
Since this trial involves implementation strategies rather than medical interventions, traditional side effects are not applicable. However, there may be indirect impacts on workflow or job satisfaction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline through study completion, an average of 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline through study completion, an average of 9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change on Implementation Climate Scale
Change on Implementation Leadership Scale
Secondary study objectives
Change on Evidence-based Practice Attitudes Scale
Change on Implementation Citizenship Behavior Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: LOCIExperimental Treatment1 Intervention
Leadership and Organizational Change for Implementation strategy
Group II: ControlActive Control1 Intervention
assessment only through online survey

Find a Location

Who is running the clinical trial?

Pacific Institute for Research and EvaluationOTHER
27 Previous Clinical Trials
33,767 Total Patients Enrolled
Oregon Social Learning CenterOTHER
35 Previous Clinical Trials
10,410 Total Patients Enrolled
Indiana UniversityOTHER
1,039 Previous Clinical Trials
1,218,694 Total Patients Enrolled

Media Library

Leadership and Organizational Change for Implementation (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05344534 — N/A
Experimental Research Study Groups: Control, LOCI
Experimental Clinical Trial 2023: Leadership and Organizational Change for Implementation Highlights & Side Effects. Trial Name: NCT05344534 — N/A
Leadership and Organizational Change for Implementation (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05344534 — N/A
~41 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top